GTBPVSNIVF• 12 Months (Normalized)
GTBP vs NIVF (GT Biopharma Inc. vs NewGenIvf Group Limited)
Showing Closing Date Range from Sep 25, 2025 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $7.1
+832.98%
GT Biopharma Inc.
Normalized Baseline0.00%
NIVF Performance $0.59
-99.94%
NewGenIvf Group Limited
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+932.92 pts
GTBP outperforming by 932.92 percentage points
GTBPNIVF
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP NIVF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(250 dates)
| Date | GTBP Price | GTBP Gain (%) | NIVF Price | NIVF Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $7.10 | +832.98% | $0.59 | -99.94% | +932.92% |
| Sep 22, 2026 | $- | $0.73 | -99.93% | - | |
| Sep 21, 2026 | $7.18 | +843.50% | $0.72 | -99.93% | +943.43% |
| Sep 18, 2026 | $7.16 | +840.87% | $0.72 | -99.93% | +940.80% |
| Sep 17, 2026 | $7.49 | +884.23% | $0.72 | -99.93% | +984.16% |
| Sep 16, 2026 | $7.81 | +926.28% | $0.79 | -99.93% | +1026.21% |
| Sep 15, 2026 | $9.00 | +1082.65% | $0.84 | -99.92% | +1182.57% |
| Sep 14, 2026 | $11.63 | +1428.25% | $0.93 | -99.91% | +1528.16% |
| Sep 11, 2026 | $8.61 | +1031.41% | $1.06 | -99.90% | +1131.31% |
| Sep 10, 2026 | $6.18 | +712.09% | $1.11 | -99.89% | +811.98% |
| Sep 09, 2026 | $5.98 | +685.81% | $1.10 | -99.89% | +785.70% |
| Sep 08, 2026 | $- | $1.11 | -99.89% | - | |
| Sep 04, 2026 | $0.24 | -68.33% | $1.14 | -99.89% | +31.56% |
| Sep 03, 2026 | $0.25 | -66.89% | $1.18 | -99.89% | +33.00% |
| Sep 02, 2026 | $0.28 | -62.81% | $1.21 | -99.88% | +37.07% |
Page 1 of 17